These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33205828)

  • 1. Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.
    Ollech A; Solomon M; Horev A; Reiss-Huss S; Ben-Amitai D; Zvulunov A; Friedland R; Atar-Snir V; Pessach-Molcho V; Barzilai A; Greenberger S
    Acta Derm Venereol; 2020 Nov; 100(18):adv00322. PubMed ID: 33205828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.
    Ollech A; Solomon M; Horev A; Reiss-Huss S; Ben-Amitai D; Zvulunov A; Friedland R; Atar-Snir V; Molho-Pessach V; Barzilai A; Greenberger S
    Acta Derm Venereol; 2020 Oct; 100(18):adv00322. PubMed ID: 33074340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
    Kämink S; Masih B; Ali N; Ullah A; Khan SJ; Ashraf S; Pylypenko T; Grobusch MP; Fernhout J; den Boer M; Ritmeijer K
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008988. PubMed ID: 33507944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
    Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
    Machado PR; Ampuero J; Guimarães LH; Villasboas L; Rocha AT; Schriefer A; Sousa RS; Talhari A; Penna G; Carvalho EM
    PLoS Negl Trop Dis; 2010 Dec; 4(12):e912. PubMed ID: 21200420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
    Ware JM; O'Connell EM; Brown T; Wetzler L; Talaat KR; Nutman TB; Nash TE
    Clin Infect Dis; 2021 Oct; 73(7):e2457-e2562. PubMed ID: 33124666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.
    Rubiano LC; Miranda MC; Muvdi Arenas S; Montero LM; Rodríguez-Barraquer I; Garcerant D; Prager M; Osorio L; Rojas MX; Pérez M; Nicholls RS; Gore Saravia N
    J Infect Dis; 2012 Feb; 205(4):684-92. PubMed ID: 22238470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CUTANEOUS LEISHMANIASIS IN ISRAEL 2016 - AN UPDATE].
    Solomon M; Schwartz E
    Harefuah; 2016 Oct; 155(10):626-631. PubMed ID: 28530056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis.
    Solomon M; Greenberger S; Milner M; Pavlotzky F; Barzilai A; Schwartz E; Hadayer N; Baum S
    Acta Derm Venereol; 2022 May; 102():adv00721. PubMed ID: 35229163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of complex cutaneous leishmaniasis (L. tropica) in a 3-year-old Syrian boy with miltefosine.
    Golle L; Sunderkötter C; Ehrenreich J; Wohlrab J
    J Dtsch Dermatol Ges; 2024 Aug; 22(8):1153-1155. PubMed ID: 38934555
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
    Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for American cutaneous and mucocutaneous leishmaniasis.
    Pinart M; Rueda JR; Romero GA; Pinzón-Flórez CE; Osorio-Arango K; Silveira Maia-Elkhoury AN; Reveiz L; Elias VM; Tweed JA
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004834. PubMed ID: 32853410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miltefosine for new world cutaneous leishmaniasis.
    Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
    Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.
    Fortin A; Caridha DP; Leed S; Ngundam F; Sena J; Bosschaerts T; Parriott S; Hickman MR; Hudson TH; Grogl M
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3144. PubMed ID: 25210745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
    Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of
    Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
    Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
    van Henten S; Tesfaye AB; Abdela SG; Tilahun F; Fikre H; Buyze J; Kassa M; Cnops L; Pareyn M; Mohammed R; Vogt F; Diro E; van Griensven J
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009460. PubMed ID: 34048461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral miltefosine to treat new world cutaneous leishmaniasis.
    Soto J; Toledo JT
    Lancet Infect Dis; 2007 Jan; 7(1):7. PubMed ID: 17182338
    [No Abstract]   [Full Text] [Related]  

  • 19. Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica.
    Killingley B; Lamb LE; Davidson RN
    Ann Trop Med Parasitol; 2009 Mar; 103(2):171-5. PubMed ID: 19208301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis].
    Costa Filho AV; Lucas IC; Sampaio RN
    Rev Soc Bras Med Trop; 2008; 41(4):424-7. PubMed ID: 18853022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.